Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus VaccineThe Motley Fool • 07/31/20
Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccineGlobeNewsWire • 07/31/20
Sanofi, GSK coronanvirus vaccine to get up to $2.1 billion from U.S. governmentMarket Watch • 07/31/20
U.S. agrees to pay Sanofi and GSK $2.1 billion for 100 million doses of coronavirus vaccineCNBC • 07/31/20
Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccineGlobeNewsWire • 07/31/20
GlaxoSmithKline, Sanofi Ink Deal With UK To Supply Up To 60M Doses of COVID-19 VaccineBenzinga • 07/29/20
Sanofi Flashes Improved Technical Strength As Big Investors Accumulate SharesInvestors Business Daily • 07/28/20
Kiadis announces publication in Blood highlighting proof-of-concept to enhance potency of anti-CD38 antibodies with Kiadis’ K-NK004, recently licensed by SanofiGlobeNewsWire • 07/22/20